| pubmed-article:11939727 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11939727 | lifeskim:mentions | umls-concept:C0042149 | lld:lifeskim |
| pubmed-article:11939727 | lifeskim:mentions | umls-concept:C0694898 | lld:lifeskim |
| pubmed-article:11939727 | lifeskim:mentions | umls-concept:C0334359 | lld:lifeskim |
| pubmed-article:11939727 | lifeskim:mentions | umls-concept:C1335177 | lld:lifeskim |
| pubmed-article:11939727 | lifeskim:mentions | umls-concept:C0597879 | lld:lifeskim |
| pubmed-article:11939727 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:11939727 | pubmed:dateCreated | 2002-4-9 | lld:pubmed |
| pubmed-article:11939727 | pubmed:abstractText | WT1 diffusely stains most ovarian serous carcinomas; reactivity of uterine papillary serous carcinomas has not been evaluated. We studied WT1 expression in 13 International Federation of Gynecology and Obstetrics stage 1 and 5 stage 3 or 4 uterine papillary serous carcinomas without ovarian metastases and compared their reactivity with the WT1 staining of 30 ovarian serous carcinomas. WT1 reactivity was evaluated with the C19 and 6F-H2 antibody clones. All 18 uterine papillary serous carcinomas were nonreactive for WT1. The nonovarian metastases of the 5 high-stage uterine papillary serous carcinomas also were nonreactive for WT1. In contrast, 29 (97%) of 30 ovarian serous carcinomas were reactive for WT1. WT1 reactivity in an unknown primary serous carcinoma would suggest it is from a nonuterine site. The mechanisms underlying these findings are unknown. They raise the possibility of genetic differences between the 2 morphologically similar neoplasms. | lld:pubmed |
| pubmed-article:11939727 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11939727 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11939727 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:11939727 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11939727 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11939727 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11939727 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:11939727 | pubmed:issn | 0002-9173 | lld:pubmed |
| pubmed-article:11939727 | pubmed:author | pubmed-author:GoldsteinNeal... | lld:pubmed |
| pubmed-article:11939727 | pubmed:author | pubmed-author:UziebloAlison... | lld:pubmed |
| pubmed-article:11939727 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11939727 | pubmed:volume | 117 | lld:pubmed |
| pubmed-article:11939727 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11939727 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11939727 | pubmed:pagination | 541-5 | lld:pubmed |
| pubmed-article:11939727 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11939727 | pubmed:meshHeading | pubmed-meshheading:11939727... | lld:pubmed |
| pubmed-article:11939727 | pubmed:meshHeading | pubmed-meshheading:11939727... | lld:pubmed |
| pubmed-article:11939727 | pubmed:meshHeading | pubmed-meshheading:11939727... | lld:pubmed |
| pubmed-article:11939727 | pubmed:meshHeading | pubmed-meshheading:11939727... | lld:pubmed |
| pubmed-article:11939727 | pubmed:meshHeading | pubmed-meshheading:11939727... | lld:pubmed |
| pubmed-article:11939727 | pubmed:meshHeading | pubmed-meshheading:11939727... | lld:pubmed |
| pubmed-article:11939727 | pubmed:meshHeading | pubmed-meshheading:11939727... | lld:pubmed |
| pubmed-article:11939727 | pubmed:meshHeading | pubmed-meshheading:11939727... | lld:pubmed |
| pubmed-article:11939727 | pubmed:meshHeading | pubmed-meshheading:11939727... | lld:pubmed |
| pubmed-article:11939727 | pubmed:meshHeading | pubmed-meshheading:11939727... | lld:pubmed |
| pubmed-article:11939727 | pubmed:meshHeading | pubmed-meshheading:11939727... | lld:pubmed |
| pubmed-article:11939727 | pubmed:meshHeading | pubmed-meshheading:11939727... | lld:pubmed |
| pubmed-article:11939727 | pubmed:meshHeading | pubmed-meshheading:11939727... | lld:pubmed |
| pubmed-article:11939727 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:11939727 | pubmed:articleTitle | WT1 immunoreactivity in uterine papillary serous carcinomas is different from ovarian serous carcinomas. | lld:pubmed |
| pubmed-article:11939727 | pubmed:affiliation | Department of Anatomic Pathology, William Beaumont Hospital, Royal Oak, MI 48073, USA. | lld:pubmed |
| pubmed-article:11939727 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11939727 | pubmed:publicationType | Comparative Study | lld:pubmed |
| entrez-gene:7490 | entrezgene:pubmed | pubmed-article:11939727 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:11939727 | lld:entrezgene |
| lhgdn:association:23900 | lhgdn:found_in | pubmed-article:11939727 | lld:lhgdn |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11939727 | lld:pubmed |
